Prof. Dr. Jörg E. Drewes is a Full Professor and Chair at the Research Institute for Urban Water Management, Technical University of Munich (TUM), Germany. He also serves as Academic Program Director for Environmental Engineering at TUM and is a co-founder of Waterloop Solutions GmbH. His work spans advanced water treatment technologies, wastewater reuse, and environmental health surveillance. Affiliations : TUM, Colorado School of Mines, King Abdullah University of Science and Technology, UNSW Water Research Centre Research focuses on advanced oxidation processes , membrane fouling mitigation , micropollutant removal , and wastewater epidemiology for public health. His team develops integrated systems for water-energy-food nexus applications and graphene oxide-based treatment solutions. Recent publications address PFAS remediation , UVC-LED pre-treatment for biofouling control, and GIS-based wastewater surveillance models . Awards include the Bayerische Staatsmedaille (2023) and William Dunbar Medal (2022). 2023 : Bayerische Staatsmedaille 2022 : William Dunbar Medal 2018 : IWA Fellow He leads the Nexus@TUM initiative and contributes to EU water resilience strategies. Collaborations include projects in Germany, China, India, and Spain, focusing on climate-resilient water systems and resource recovery .
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Prof. Friederike Ebner holds the Chair of Infection Pathogenesis at the Technical University of Munich (TUM) since 2023, within the TUM School of Life Sciences. Her research focuses on the immunobiology of parasite infections, particularly studying gastrointestinal helminths like Ascaris suum and their interactions with host immune systems to design novel intervention strategies. She also develops biomedical models for studying infectious diseases. Educational Background: Friederike Ebner earned a biotechnology degree from TU Berlin and Dongseo University (South Korea). She completed her PhD in biology at Humboldt University Berlin (2014), followed by postdoctoral research in immunology at Freie Universität Berlin, where she became an assistant professor before moving to TUM. Research Interests: Her work spans helminth-host immune dynamics, vaccine development, microbiome interactions in parasitic infections, and translational models for human diseases. Key topics include Th2/Th1 immune balance, helminth-derived immunomodulators, and xenotransplantation safety. Notable Contributions: Her recent studies address diagnostic methods for ascariasis, microbiome roles in helminth survival, and immunotherapeutic applications of parasite products. Current efforts emphasize bridging fundamental immunology with clinical and veterinary applications. Professional Activities: Prof. Ebner teaches immunology and parasite biology at TUM while maintaining active collaborations in global health and infectious disease research. She advocates for interdisciplinary approaches to address knowledge gaps in parasitology and vaccinology.
Prof. Oliver Seitz leads the Bioorganic Synthesis research group at the Department of Chemistry, Faculty of Mathematics and Natural Sciences, Humboldt University of Berlin. His lab focuses on cutting-edge chemical biology approaches for protein/nucleic acid interrogation, with recent work advancing DNA/RNA-programmed assemblies for cellular imaging and therapeutic applications. Research spans chemical protein synthesis, glycoprotein/phosphoprotein engineering, and nucleic acid-templated reactions. Key innovations include Forced Intercalation (FIT) probes for wash-free RNA imaging, loss-of-affinity principles for catalytic efficiency, and peptide-PNA conjugates for targeted cellular delivery. The group actively develops tools for live-cell protein labeling and biomolecular spatial screening. Recent publications (2021-2024) emphasize fluorescence-based detection systems, catalytic templated reactions, and therapeutic peptide synthesis. Trends show increasing sophistication in multi-dye probes, glycan engineering, and RNA-triggered pro-drug activation. Scientific awards include: Max Bergmann Award (2019) Prof. Seitz actively advises doctoral students, with recent graduates Marvin Björn Stutz (2023, magna cum laude ), Dino Gluhacevic von Krüchten (2023, summa cum laude ), and Sophie Schöllkopf (2023, magna cum laude ). Current PhD candidates include Ekaterina Kazakova (glycoprotein synthesis), Alina Herfort (phosphoproteins), and Lina-Marie Beck (peptide-nucleic acid conjugates), with postdocs like Dr. Mandana Oloub (viscosity sensors). The Bioorganic Synthesis lab operates within Berlin's vibrant chemical research ecosystem, utilizing specialized techniques for chemical protein synthesis and nucleic acid detection. Recent team growth reflects ongoing projects in RNA imaging, catalytic templated reactions, and therapeutic conjugate development, supported by open positions for new researchers.
Dr. Andrew Bassett serves as Head of the Cellular and Gene Editing Research group at the Wellcome Sanger Institute, where he develops cutting-edge genome engineering techniques using human pluripotent stem cells to investigate neurodegenerative diseases including Alzheimer's and Parkinson's. His work focuses on scaling genetic screening approaches and improving CRISPR specificity for modeling complex disease mechanisms. His academic training includes: PhD at the MRC Laboratory of Molecular Biology (MRC-LMB) with Andrew Travers on chromatin remodelling in heterochromatin formation Postdoctoral research with David Baulcombe at the University of Cambridge studying small RNA roles in chromatin modification Additional postdoctoral work with Chris Ponting at the MRC Functional Genomics Unit (MRC-FGU) in Oxford, where he pioneered CRISPR applications in Drosophila Bassett's research program centers on developing advanced genome engineering methodologies for precise modulation of gene expression networks during development and neurodegeneration. His group specializes in creating complex editing events (SNPs, paired knockouts, enhancer perturbations) within iPSC-derived models, with particular emphasis on epigenetic regulation and transcriptional control. Current projects integrate single-cell 'omics and phenotypic assays to decode genetic causes of neurodegenerative disorders through the OpenTargets consortium. Analysis of his 15 most recent publications reveals dominant trends in CRISPR technology development (35%), neurodegenerative disease modeling (30%), and single-cell functional genomics (25%). His work consistently bridges methodological innovation with disease mechanism studies, increasingly incorporating multi-omics approaches and expanding into cancer immunology and infectious disease applications since 2022. As group leader, Bassett mentors postdoctoral researchers and PhD students while securing major funding for genome engineering initiatives. His team operates within the Sanger Institute's Cellular Operations division and maintains critical partnerships with the OpenTargets consortium for therapeutic target validation. The laboratory specializes in high-throughput screening platforms using iPSC-derived neural and microglial models, with recent methodological advances including scSNV-seq and ONE-STEP tagging systems that significantly enhance precision genome editing capabilities.
Dr. Lara Urban is a Principal Investigator at Helmholtz Munich and Helmholtz AI, and a TUM Junior Fellow at the Technical University of Munich's Life Sciences School. Her research integrates genomics and artificial intelligence to address One Health challenges, focusing on environmental health, biodiversity conservation, and pathogen surveillance. She holds a PhD from EMBL-EBI and the University of Cambridge (2019) and Master's degrees from Julius-Maximilians-University of Würzburg (2015). Her work leverages portable genomic technologies for real-time data analysis in clinical, environmental, and conservation contexts. Key areas include studying bioaerosols, pathogen detection, and genomic diversity in endangered species like the kākāpō. Awards include the Young Scientist of the Year 2022 and Humboldt Research Fellowship. Her team has published on nanopore sequencing applications, antibiotic resistance, and conservation genomics. Collaborations span institutions like the University of Zurich and ETH Zurich, funded by EU Horizon Europe, BMBF, and Helmholtz grants. Current initiatives include fieldwork in Chile and advancing genomic equity through democratized tools.
Rainer Böckmann is a Professor of Computational Biology in the Department of Biology at Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany, where he leads the Group for Theoretical and Computational Membrane Biophysics. His research integrates molecular dynamics simulations with biophysical analysis to study membrane structure, dynamics, and function. Research Interests: His work focuses on computational biophysics, particularly lipid bilayers, membrane proteins, molecular dynamics, and structural bioinformatics. He investigates how lipid composition, cholesterol, and embedded peptides influence membrane organization, curvature, and permeability, with applications in antimicrobial strategies and mRNA vaccine delivery systems. Recent Research Trends: His recent publications reflect a strong emphasis on lipid nanoparticles (LNPs), particularly their phase behavior, pH-dependent protonation, and structural transitions relevant to mRNA vaccines. He also explores antimicrobial peptides, membrane domain formation, and the role of cholesterol in modulating membrane properties. His group develops and applies advanced simulation techniques, including constant-pH MD and coarse-grained modeling. Member of Editorial Board, Biophysical Journal (2024–present) Elected Member, DFG Review Board for Biophysics (2020–present) Chairman, Molecular Biophysics Section, German Biophysical Society (2011–2012) Leadership and Service: Böckmann is actively involved in academic governance, serving on editorial boards, DFG committees, and as a guest editor for special issues in Frontiers journals. He contributes to graduate education and high-performance computing initiatives at FAU, including the NHR@FAU and Life@FAU Graduate School. He has organized major conferences and workshops in biophysics and membrane modeling. Laboratory and Collaboration: He leads a research group focused on biomembrane physics, collaborating with experimentalists and theorists. His lab develops and applies simulation tools to study membrane systems, bridging computational insights with biological function.
Rainald Loehner is a Distinguished Professor of Fluid Dynamics at George Mason University's Center for Computational Fluid Dynamics. Since 2003, he has led the Center for Computational Fluid Dynamics at George Mason University. He is currently a Hans Fischer Senior Fellow at the Technical University of Munich's Institute for Advanced Study (TUM-IAS) for 2023, hosted by Professors Kai-Uwe Bletzinger and Roland Wüchner in the 'Adjoint-Based System Identification of Large-Scale Structures' Focus Group. Loehner received his Diplom Ingenieur (Maschinenbau) degree from the Technical University of Braunschweig, and his PhD and a DSc in civil engineering from the University College of Swansea, Wales. After teaching at Swansea for a year, he worked at the Naval Research Laboratory in Washington, DC, followed by a research professorship at George Washington University. He joined George Mason University as an associate professor and was promoted to full professor in 1995 and distinguished professor in 2004. With over 35 years of experience, Professor Loehner's research spans the complete pipeline of numerical solvers and simulation tools. His expertise includes pre-processing, grid generation, numerical methods, field solvers, parallel computing, adaptive mesh refinement, fluid-structure interaction, shape optimization, system identification, and computational crowd dynamics. His current work focuses on developing advanced field solvers for compressible and incompressible flows, acoustics, electromagnetic wave propagation, heat and mass transfer, structural mechanics, and fluid-structure interaction. Key application areas include blast mitigation, ship hydrodynamics, blood flow, contaminant transport, and pedestrian safety. Loehner's recent research output (2020-2024) shows a strong trend toward digital twin technology and adjoint-based methods for structural analysis and optimization. His publications focus on high-fidelity digital twins for detecting structural weaknesses, risk assessment in engineering systems, and optimization of sensor placement. His work bridges computational mechanics with machine learning approaches, particularly in system identification and inverse problems, demonstrating how computational methods can solve complex real-world engineering challenges. 2020: Ranked #15119 in the Stanford List of Most Influential Scientists of the World; #8 in Aerospace and Aeronautics 2010: Distinguished International Career Award, Argentine Association of Computational Mechanics 2008: Fellow, International Association for Computational Mechanics 2006: Associate Fellow, AIAA 2005: Honorary Professor, University of Wales Swansea 2005: Advisory Professor, Shanghai Jiao Tong University 2004: Distinguished Professor of Fluid Dynamics, George Mason University 1999: Computational Mechanics Achievements Award, Japan Society of Mechanical Engineering 1993: Doctor of Science in Civil Engineering, University College of Swansea 1979-1983: Studienstiftung des Deutschen Volkes (Top 1% of German Students) Professor Loehner has mentored numerous students through his work at George Mason University and has supervised research in computational fluid dynamics, structural mechanics, and related fields. His research has been supported by various grants from government agencies and industry partners, enabling the development of advanced simulation tools applied in aerodynamics, hydrodynamics, shock-structure interaction, and medical applications. His codes and methods have been widely adopted in industry and academia for applications ranging from aircraft and ship design to medical simulations and urban pathogen transmission modeling. Loehner leads the Center for Computational Fluid Dynamics at George Mason University, which focuses on developing cutting-edge computational methods for fluid dynamics and related multiphysics problems. The center works on strategic application areas including blast mitigation, ship hydrodynamics, blood flow simulation, and pedestrian movement modeling. As a TUM-IAS Fellow, he collaborates with the Chair of Computational Modeling and Simulation at TUM on adjoint-based system identification of large-scale structures, bringing together expertise in computational mechanics and digital twin technology to address complex engineering challenges.
Prof. Dr. Kirsten Jung is a faculty member at the Department of Microbiology , Faculty of Biology , Ludwig Maximilian University of Munich . Her research focuses on bacterial signal transduction, stress response mechanisms, and systems biology approaches to understand microbial regulatory networks. Key research areas include stress-dependent gene expression in bacterial populations Structural and functional analysis of membrane-integrated receptors Metabolism-based chemical communication in bacteria Integration of experimental and computational systems biology Recent publications highlight her lab's work on Escherichia coli epitranscriptomic modifications under heat stress, m 5 C rRNA dynamics, and the role of RNA methylation in host-pathogen interactions. Collaborative studies address bacterial acid stress responses and their implications for antibiotic tolerance. Her interdisciplinary work bridges microbiology with ecological studies, as evidenced by research on biodiversity conservation in forest and urban ecosystems. Publications also demonstrate expertise in advanced imaging techniques (e.g., arterial spin labeling for glioma analysis) and bioinformatics approaches. Current advisees include Gloria Gessinger and Tania P. Gonzalez-Terrazas . She can be contacted at jung@lmu.de .
Prof. Laura Na Liu is a Professor and Director at the 2nd Physics Institute, University of Stuttgart, with a dual affiliation at the Max Planck Institute for Solid State Research. Her research bridges nanophotonics, DNA nanotechnology, and plasmonics, focusing on dynamic systems for biomedical applications, optical metamaterials, and synthetic biology. Key contributions include DNA-templated plasmonic architectures, reconfigurable metasurfaces, and synthetic cell components using DNA nanotechnology. Academic training includes advanced work in physics and materials science, with a career spanning leading institutions. Research interests emphasize the interplay between nanoscale structures and optical/chemical functionalities. Recent publications highlight innovations in programmable nanomaterials, real-time molecular tracking, and high-performance holography systems. Her work integrates experimental and theoretical approaches, addressing challenges in biophotonics, nanoelectronics, and smart materials. Awards and recognitions are listed in institutional records, while her lab actively collaborates with industry on applied photonics solutions.
Professor Wolfgang Fritzsche serves as Head of the Nanobiophotonics Department at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany, where he leads cutting-edge research at the intersection of nanotechnology and photonics. His laboratory, located in HG 269, maintains active collaborations across multiple international institutions as evidenced by his extensive publication record. Dr. Fritzsche's research spans multiple nanotechnology domains with particular emphasis on plasmonic nanoparticles, nanozymes, and optical sensing platforms. His work demonstrates exceptional versatility across fundamental nanomaterial synthesis and practical biomedical applications. Recent projects include developing innovative antibiofilm agents using β-cyclodextrin inclusion complexes, engineering laccase-mimetic nanozymes for food safety monitoring, and creating plasmonic nanocomposites for antibacterial applications. His expertise in localized surface plasmon resonance (LSPR) sensing has led to significant advancements in real-time monitoring of nanomaterial interactions and biosensing platforms. Analysis of his recent publication trajectory reveals a strategic research focus on translating nanomaterial discoveries into practical diagnostic and therapeutic applications. His work demonstrates increasing integration of multiple nanotechnology approaches, particularly combining plasmonics with enzymatic mimetics and advanced imaging techniques. The consistent high-impact journal placements across chemistry, materials science, and biomedical engineering publications indicate strong cross-disciplinary recognition of his contributions to nanobiophotonics. While no specific awards are mentioned in the available documentation, Professor Fritzsche's leadership position at a Leibniz Association institute and his prolific publication record in top-tier journals represent significant professional recognition. His research program appears well-funded through the substantial output of collaborative papers spanning multiple application areas. Professor Fritzsche maintains an active research laboratory focused on nanobiophotonics, with particular expertise in plasmonic nanoparticle synthesis, surface functionalization techniques, and optical biosensing platforms. His team appears to specialize in bridging fundamental nanomaterial properties with practical biomedical applications, particularly in infection control, cancer therapy, and diagnostic technologies. The interdisciplinary nature of his publications suggests collaboration across chemistry, physics, biology, and medical research domains.
Sven Hermann is a Senior Lecturer at the European Institute for Molecular Imaging (EIMI) within the University of Münster, leading the Preclinical Imaging Group. His research focuses on developing molecular imaging strategies for inflammation and infection, including PET, SPECT, fluorescence reflectance imaging, and optoacoustic imaging. Key targets include matrix metalloproteinases (MMPs) and alarmins (S100A8/S100A9), with applications in cardiovascular diseases, rheumatoid arthritis, and bacterial imaging. He participates in the Cells in Motion Cluster of Excellence and leads DFG-funded projects TRR332-C07 and CRC1450-C03, investigating immune regulation and imaging techniques. Affiliations: EIMI, University of Münster; Core Unit Pix (preclinical imaging). Research Themes: Bacterial imaging via maltodextrin transporters, MMP activity visualization in atherosclerosis, and S100A8/A9-driven immune modulation. His work integrates engineering and biology to translate imaging innovations into clinical applications, emphasizing multimodal approaches for disease monitoring.
Prof. Dr. Andreas Pichlmair is an Associate Professor at the Technical University of Munich (TUM) since 2017, leading the Immunopathology of Viral Infections group within the TUM School of Medicine and Health . His research focuses on understanding virus-host interactions, particularly the innate immune response to viral pathogens. He earned his DVM (2004) from the University of Freiburg and PhD (2008) from Cancer Research UK, followed by postdoctoral work at the Center for Molecular Medicine in Vienna (2008-2011) and a Max Planck Free Floater Program (2011-2017). Research Interests : His lab investigates viral sensing mechanisms, antiviral immunity, and systems-level proteomic approaches to dissect host-pathogen dynamics. Key areas include RIG-I signaling, IFIT protein function, and novel cell death pathways like oxeiptosis. His work integrates mass spectrometry, functional genomics, and in vivo models to identify host factors critical for viral replication and immune evasion. Awards : Loefler Frosch Prize (2013) Pontecorvo Prize (2008) Golden Badge of Honor (2006) Lab Team : Includes PhD students (e.g., Valter Bergant, Yiqi Huang) and postdocs (e.g., Pietro Scaturro, Alexey Stukalov). The group collaborates extensively on SARS-CoV-2 research and antiviral drug discovery.
Michael Nothnagel is a Professor at the University of Cologne, where he leads the Department of Statistical Genetics and Bioinformatics within the Cologne Center for Genomics (CCG). His work spans statistical genetics, genetic epidemiology, and forensic genetics, focusing on methodological development and large-scale genomic data analysis. His research interests encompass theoretical and applied statistical genetics, with emphasis on human genetic diversity, disease etiology, and forensic applications. Key areas include Y-chromosomal phylogeography, genome-wide association studies for complex diseases, development of statistical methods for variant interpretation, and forensic marker optimization. His group leverages next-generation sequencing data and specialized forensic markers to address questions in population history, disease mechanisms, and identification systems. Recent publications reveal a strong focus on computational approaches to genetic analysis, including spatial frequency interpolation for haplogroup mapping, polygenic risk score applications for behavioral traits, and advanced methods for variant classification. His work demonstrates consistent integration of statistical theory with practical applications in medical and forensic genetics, often through international collaborations like the VISAGE Consortium. Nothnagel maintains active involvement in the Cologne Center for Genomics, contributing to seminars and collaborative projects including the upcoming 34th International Genetic Epidemiology Society meeting. His research group operates at the intersection of computational biology and medicine, with particular strengths in handling complex genomic datasets and developing novel analytical frameworks for genetic epidemiology.
Romney M. Humphries, Ph.D., D(ABMM), M(ASCP), is a Professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, serving as Medical Director of the Microbiology Laboratory. Their research focuses on advancing diagnostic technologies for antibiotic-resistant infections and studying real-time evolution of antimicrobial resistance mechanisms. Academic Rank: Professor Department: Pathology, Microbiology, and Immunology Key research areas include antimicrobial resistance , diagnostic innovation , and clinical microbiology . The Humphries laboratory specializes in evaluating rapid identification methods for multidrug-resistant pathogens and novel antimicrobial development. Recent publications highlight advancements in MALDI-TOF MS, CRISPR diagnostics, and regulatory frameworks for laboratory-developed tests. Scientific contributions appear in journals such as New England Journal of Medicine , Clinical Infectious Diseases , and Journal of Clinical Microbiology . Current work emphasizes integrating genotypic/phenotypic testing for improved patient outcomes and informing federal policies on diagnostic standardization.
